Back to results
US 2012/0070445 A1Published application
Brain-derived gonadotropins and cognition
OwnerMark A. Smith, Kate M. Webberinventors
Life of this patent
Estimating the term…
Abstract
A method of treating or preventing neurodegenerative disease in a subject, the method includes administering to the subject a therapeutically effective amount of at least one physiologically acceptable agent that modulates levels, production, and/or function of brain-derived hormones of the hypothalamic-pituitary-gonadal (HPG) axis or their receptors.
Claims16
1-8. (canceled)
A method of treating or preventing neurodegenerative disease in a subject, the method comprising:
- administering to the subject a therapeutically effective amount of at least one physiologically acceptable agent that reduces or eliminates brain-derived gonadotropin and/or gonadotropin receptor levels in the subject.
A method of treating or preventing Alzheimer disease in a subject, the method comprising:
- administering to a subject a therapeutically effective amount of at least one physiologically acceptable agent that reduces or eliminates brain derived gonadotropins and/or brain derived gonadotropin receptors in the subject.
Dependencies are inferred from the claim text.